Abstract 4371670: Higher Post-Ablation Scar Shifts Recurrence Towards Flutter
Background: Atrial arrhythmia recurrence remains a common challenge after catheter ablation. While both atrial fibrillation (AF) and atrial flutter (AFL) may recur, the relationship between post-ablation scar burden and the predominant type of arrhythmia recurrence remains incompletely defined. Hypothesis: To evaluate whether higher post-ablation fibrosis burden is associated with a shift in recurrence pattern favoring atrial flutter over atrial fibrillation. Methods: This post hoc analysis included 337 patients from the prospective randomized multicenter DECAAF-II trial who experienced recurrence of atrial arrhythmia after catheter ablation (278 with AF, 59 with AFL). All participants underwent LGE-MRI before and 3 months after ablation to assess left atrial (LA) fibrosis, volume, and post-ablation scar. Baseline demographics as well as the substrates and post-ablation scar burden were compared between AF and AFL recurrence groups using Wilcoxon tests, t-tests, and Chi-square tests accordingly. Results: Baseline atrial substrate was similar between recurrence groups (Table 1). No significant differences were observed in baseline fibrosis (AF: 19.16 ± 7.65% vs. AFL: 19.53 ± 7.83%, p = 0.69), left atrial volume (138.92 ± 42.19 mL vs. 141.74 ± 47.25 mL, p = 0.82), or left atrial volume index (66.81 ± 25.19 vs. 67.40 ± 20.24 mL/m2, p = 0.82). Treatment allocation, demographic factors, and comorbidities were also similar across groups. In contrast, post-ablation scar burden was significantly higher in patients with AFL recurrence (10.46 ± 5.41%) compared to those with AF recurrence (8.75 ± 4.90%, p = 0.015). Conclusion: More scar means less AF and more flutter. Greater post-ablation fibrosis shifts recurrence toward organized rhythms that may be easier to manage clinically.
Authors
- Amitabh C. Pandey (ORCID: https://orcid.org/0000-0002-1541-7023)
- Nassir F. Marrouche (ORCID: https://orcid.org/0000-0003-0454-0541)
- Hadi Younes (ORCID: https://orcid.org/0000-0002-7202-1164)
- Karl Abou Zeid
- Omar Kreidieh (ORCID: https://orcid.org/0000-0001-6189-2821)
- Ala Assaf (ORCID: https://orcid.org/0000-0001-6443-798X)
- Yingshuo Liu (ORCID: https://orcid.org/0000-0003-4780-8384)
- Ghassan Bidaoui (ORCID: https://orcid.org/0000-0002-3562-7386)
- Chanho Lim (ORCID: https://orcid.org/0000-0001-9998-5601)
- Michel Abou Khalil (ORCID: https://orcid.org/0009-0007-2038-7678)
- Joe Abi‐Rached (ORCID: https://orcid.org/0000-0003-3227-6143)
- Mayana Bsoul
- Mohammad Montaser Atasi (ORCID: https://orcid.org/0009-0008-2046-209X)
- Tarek Nahle (ORCID: https://orcid.org/0009-0004-4584-3308)
- Christian M. Massad (ORCID: https://orcid.org/0009-0002-3441-0617)
- Swati Rao (ORCID: https://orcid.org/0000-0001-8460-8408)
- Abboud Hassan (ORCID: https://orcid.org/0009-0001-4263-9553)
- Yara Menassa (ORCID: https://orcid.org/0009-0008-4304-603X)
Institutions
- Tulane University (US)
- Saint Joseph University (LB)
- Augusta University Health (US)
Publication Details
- Journal
- Circulation
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1161/circ.152.suppl_3.4371670
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00